The relationship between inflammatory markers and retinopathy of prematurity in extremely premature infants
Graefe's Archive for Clinical and Experimental Ophthalmology · 2025
DOI: 10.1007/s00417-024-06604-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Graefe's Archive for Clinical and Experimental Ophthalmology, 2025. Verfasst von Fatma Merve Bektaş und 3 weiteren Autor:innen. Beteiligte Einrichtung: Ophthalmology Clinic, Mersin City Training and Research Hospital, Mersin, Turkey. fmerveb@gmail.com. Hauptthemen laut MEDLINE: Retinopathy of Prematurity, Infant, Extremely Premature, Biomarkers, Inflammation. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 36 Literaturangaben.
Themen: Neonatologie
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Ophthalmology Clinic, Mersin City Training and Research Hospital, Mersin, Turkey. fmerveb@gmail.com.
- Ophthalmology Clinic, Mersin City Training and Research Hospital, Mersin, Turkey.
- Neonatology Clinic, Mersin City Training and Research Hospital, Mersin, Turkey.
Zitieren
APA
Bektaş, F. M., Güçlü, E. S., Şimşek, H., & Akçali, M. (2025). The relationship between inflammatory markers and retinopathy of prematurity in extremely premature infants. Graefe's Archive for Clinical and Experimental Ophthalmology. https://doi.org/10.1007/s00417-024-06604-9
Vancouver
Bektaş FM, Güçlü ES, Şimşek H, Akçali M. The relationship between inflammatory markers and retinopathy of prematurity in extremely premature infants. Graefe's Archive for Clinical and Experimental Ophthalmology. 2025. doi:10.1007/s00417-024-06604-9
BibTeX
@article{Bekta2025,
author = {Bektaş, Fatma Merve and Güçlü, Emin Serbülent and Şimşek, Hüseyin and Akçali, Mustafa},
title = {The relationship between inflammatory markers and retinopathy of prematurity in extremely premature infants},
journal = {Graefe's Archive for Clinical and Experimental Ophthalmology},
year = {2025},
doi = {10.1007/s00417-024-06604-9}
}
EUVIMED